WilliamCharlesKreislMD

Neurology • New York, NY

Assistant Professor of Neurology (in the Taub Institute for Research on Alzheimer's Disease and the Aging Brain)

Join to view full profile

Dr. Kreisl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kreisl's full profile

Already have an account?

Office
CUIMC/Neurological Institute of New York
710 West 168th Street
New York, NY 10032
Phone+1 646-426-3876

Education & Training

National Institute of Mental HealthClinical Research Fellowship, 2007 - 2012
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2003 - 2007
Virginia Commonwealth University School of MedicineClass of 2003, MD
Cornell UniversityBA, Neurobiology and Behavior, 1995 - 1999

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2006 - 2025
MD State Medical License 2013 - 2014
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Imaging Tau in Alzheimer's Disease and Normal Aging Start of enrollment: 2017 Dec 11
Completed
Phase 2
Imaging Inflammation in Alzheimer's Disease With 11C-ER176 Start of enrollment: 2018 Sep 10
Completed
Phase 1, Phase 2

Publications & Presentations

PubMed

Relationship Between Alzheimer Disease Imaging Biomarkers and Performance on the NIH Toolbox Cognition Battery in Late-middle Age Hispanics.
Mouna Tahmi, Brady Rippon, Priya Palta, Greysi Sherwood, Gabriela Hernandez
Alzheimer Disease and Associated Disorders. 2024-11-26
2 citations
Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model.
Samantha M Rossano, Aubrey S Johnson, Anna Smith, Galen Ziaggi, Andrew Roetman
Alzheimer's & Dementia. 2024-04-01
1 citations
Psychotic symptoms are associated with elevated tau PET signal in the amygdala independent of Alzheimer's disease clinical severity and amyloid burden.
Aubrey S Johnson, Galen Ziaggi, Anna C Smith, Hannah Houlihan, Lauren B Heuer
Medrxiv. 2024-01-13

Press Mentions

Cerveau Technologies, Inc. Signs Research Agreement with Columbia University Medical CenterOctober 19th, 2017
Can Alzheimer's Pass the 'Sniff Test'?July 26th, 2016
A Sniff Test for Alzheimer's Checks for the Ability to Identify OdorsJuly 26th, 2016

Grant Support

Longitudinal imaging of microglial activation in clinical variants of Alzheimer's diseaseNational Institute on Aging2020–2025
Imaging inflammation and tau in elders with different clinical and biomarker profiles of Alzheimer's diseaseNational Institute on Aging2016–2021